|
健保碼及健保價 |
|
See related Certican tab[卓定康 錠] information |
|
|
|
製造商 |
Novartis |
|
代理/經銷商 |
Novartis |
|
成份 |
Everolimus |
|
適應症 |
In combination with ciclosporin for microemulsion & corticosteroids for prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving an allogeneic cardiac and renal transplant. |
|
用量 |
Adult Initially 0.75 mg bid after transplant, then maintain at lowest blood concentration of 3-8 ng/mL. |
|
過量 |
View Certican[卓定康] overdosage for action to be taken in the event of an overdose. |
|
用法 |
May be taken with or without food (Take consistently either always w/ or always w/o meals. Avoid grapefruit juice. Swallow whole, do not chew/ crush.). |
|
美國食品藥物管理局之懷孕等級 |
Category D: There is positive evidence of human foetal risk, but the benefits from use in pregnant women may be acceptable despite the risk (e.g., if the drug is needed in a life-threatening situation or for a serious disease for which safer drugs cannot be used or are ineffective). |
|
禁忌 |
[Click for Certican[卓定康] detailed prescribing infomation] |
|
注意事項 |
Hepatic impairment. Monitor patients for skin neoplasms; minimise exposure to UV light & sunlight. Increased susceptibility to infections. Established hyperlipidemia. Monitor renal function. Avoid in rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption. Pregnancy & lactation. |
|
不良反應 |
Leucopenia, hypercholesterolemia, hyperlipidemia; viral, bacterial & fungal infections, sepsis; thrombocytopenia, anemia, coagulopathy, thrombotic, thrombocytopenic purpura/hemolytic uremic syndrome; hypertriglyceridemia; hypertension, lymphocele, venous thromboembolism; pneumonia, abdominal pain, diarrhea, nausea, vomiting, pancreatitis, UTI, edema, pain.
View ADR Monitoring Website[參閱藥物不良反應監測表格] |
|
交互作用 |
Strong & moderate CYP3A4 inhibitors/inducers.
View more drug interactions with Certican[卓定康] |
|
描述 |
View Certican[卓定康] description for details of the chemical structure and excipients (inactive components). |
|
作用 |
View Certican[卓定康] mechanism of action for pharmacodynamics and pharmacokinetics details. |
|
本商品之市售規格 |
|
劑型 |
包裝 |
圖片 |
|
Certican 錠劑 |
|
Certican 0.25 mg x 60's |
 |
|
Certican 0.5 mg x 60's |
 |
|
Certican 0.75 mg x 60's |
|
|
|
Manufacturer: |
Novartis |
|
Distributor: |
Novartis
|
|
|
|
